查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1554230

美国动脉粥状硬化斑块切除术设备市场规模、份额、趋势分析报告：按产品类型、应用、最终用途、细分市场预测，2024-2030 年

U.S. Atherectomy Devices Market Size, Share & Trends Analysis Report By Product Type (Directional Atherectomy Systems, Orbital Atherectomy Systems), By Application, By End Use, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10个工作天内

价格
简介目录

美国动脉粥状硬化斑块切除术设备市场成长与趋势

Grand View Research最新报告显示，到2030年，美国动脉粥状硬化斑块切除术设备市场规模预计将达到9.387亿美元，2024年至2030年复合年增长率为4.9%。

由于目标疾病盛行率上升和对血管内治疗的偏好，预计该区域市场将出现良好成长。此外，对微创手术的需求不断增长将推动市场成长。与侵入性手术相比，这些手术疼痛更轻，恢復也更快。

此外，由于切口少、术后併发症少、死亡率低等优点，患者满意度高，也推动了动脉粥状硬化斑块切除术设备市场的成长。实现早期诊断的技术进步也可能在不久的将来促进市场成长。例如，2017 年 1 月，Medtronic ) 的 HawkOne定向动脉粥状硬化斑块切除术系统获得 CE 标誌核准，用于治疗周边动脉疾病(PAD) 患者。

美国动脉粥状硬化斑块切除术设备市场报告亮点

  • 定向动脉粥状硬化斑块切除术系统在市场上占据主导地位，2023 年市占率将达到 37.2%。
  • 由于在这种环境下进行了大量的周边血管介入（PVI）手术，预计办公室实验室（OBL）将成为预测期内成长最快的部分。
  • 此外，更少的併发症和后续观察可以降低成本并增加新技术的采用，从而带来更好的健康结果。
  • 正在进行的多项临床试验及其积极结果将加速新技术的渗透。例如，雅培 (Abbott) 于 2023 年 4 月收购了医疗设备製造商心血管系统公司 (CSI)，增强了其治疗週边动脉和冠状动脉疾病患者的能力。
  • 主要企业包括 Abbott、Boston Scientific、B.Braun SE、AngioDynamics、Terumo Medical Corp、Cardioangio Systems, Inc、Medtronic PLC、Avinger, Inc、ST.JUDE MEDICAL, Inc。

目录

第一章调查方法和范围

第 2 章执行摘要

第 3 章美国动脉粥状硬化斑块切除术设备市场变数、趋势、范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 美国动脉粥状硬化斑块切除术设备市场分析工具
    • 波特的分析
    • PESTEL分析

第四章美国动脉粥状硬化斑块切除术设备市场：依产品估算与趋势分析

  • 细分仪表板
  • 美国动脉粥状硬化斑块切除术设备市场：2023 年和 2030 年产品变化分析
  • 定向动脉粥状硬化斑块切除术系统
  • 眼眶动脉粥状硬化斑块切除术系统
  • 光学消融（雷射）动脉粥状硬化斑块切除术系统
  • 旋转斑块动脉粥状硬化斑块切除术系统

第五章美国动脉粥状硬化斑块切除术设备市场：按应用估计和趋势分析

  • 细分仪表板
  • 美国动脉粥状硬化斑块切除术设备市场：2023 年和 2030 年应用变化分析
  • 周围血管
  • 神经血管的
  • 心血管

第六章美国动脉粥状硬化斑块切除术设备市场：最终用途的估计和趋势分析

  • 细分仪表板
  • 美国动脉粥状硬化斑块切除术设备市场：2023 年和 2030 年最终用途变化分析
  • 医院
  • 门诊治疗中心
  • 其他的

第七章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Abbott
    • B. Braun SE
    • Boston Scientific Corporation
    • BD
    • AngioDynamics Inc.
    • Biomerics LLC
    • Terumo Corporation
    • Medtronic
    • Koninklijke Philips NV
简介目录
Product Code: GVR-2-68038-799-5

U.S. Atherectomy Devices Market Growth & Trends:

The U.S. atherectomy devices market size is expected to reach USD 938.7 million by 2030, expanding at a CAGR of 4.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. The regional market is expected to witness lucrative growth due to the rising prevalence of target diseases and preference for endovascular procedures. Moreover, rising demand for minimally invasive procedure will boost the market growth. Such procedures are less painful and allow quicker recovery than invasive procedures.

Other advantages, such as higher patient satisfaction owing to fewer incision wounds, few post-surgical complications, and low mortality rates, are also driving the atherectomy devices market growth. Technological advancements allowing early diagnosis are also likely to augment the market growth in the near future. For instance, in January 2017, Medtronic received CE mark approval for HawkOne directional atherectomy system for treating patients suffering from Peripheral Artery Disease (PAD).

U.S. Atherectomy Devices Market Report Highlights:

  • Directional atherectomy systems dominated the market and accounted for a share of 37.2% in 2023.
  • Office-Based Labs (OBLs) is anticipated to be the fastest-growing segment in the forecast period due to a greater number of Peripheral Vascular Interventional (PVI) procedures being performed in this setting
  • In addition, lesser number of complications and follow-up procedures lowers the cost and increases the adoption of new technologies delivering better health outcomes, which is anticipated to propel the market growth in the coming years
  • Several ongoing trials and their positive results facilitate penetration of novel technologies. For instance, Abbott acquired the medical device company Cardiovascular Systems, Inc. (CSI) in April 2023 to enhance its capabilities to treat patients with peripheral and coronary diseases.
  • Some of the key companies are Abbott; Boston Scientific Corp.;B. Braun SE; AngioDynamics; Terumo Medical Corp.; Cardiovascular Systems, Inc.; Medtronic PLC; Avinger, Inc.; ST. JUDE MEDICAL, Inc.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Atherectomy Devices Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. U.S. Atherectomy Devices Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. U.S. Atherectomy Devices Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Atherectomy Devices Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Directional Atherectomy Systems
    • 4.3.1. Directional Atherectomy Systems Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Orbital Atherectomy Systems
    • 4.4.1. Orbital Atherectomy Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Photo-ablative (Laser) Atherectomy Systems
    • 4.5.1. Photo-ablative (Laser) Atherectomy Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Rotational Atherectomy Systems
    • 4.6.1. Rotational Atherectomy Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Atherectomy Devices Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Atherectomy Devices Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Peripheral Vascular
    • 5.3.1. Peripheral Vascular Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Neurovascular
    • 5.4.1. Neurovascular Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Cardiovascular
    • 5.5.1. Cardiovascular Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. Atherectomy Devices Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Atherectomy Devices Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Hospitals
    • 6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Ambulatory Care Centers
    • 6.4.1. Ambulatory Care Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Abbott
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. B. Braun SE
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Boston Scientific Corporation
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. BD
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. AngioDynamics Inc.
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. Biomerics LLC
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Terumo Corporation
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Medtronic
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. Koninklijke Philips NV
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives